4D Molecular Therapeutics, Inc. (FDMT) ownership: Top institutional holder: JANUS HENDERSON GROUP PLC ($48.87M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 5247151.00 | $48.87M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 5049779.00 | $47.01M | 2026-03-31 |
| GOLDMAN SACHS GROUP INC | 4205438.00 | $39.15M | 2026-03-31 |
| BlackRock, Inc. | 4145303.00 | $38.59M | 2026-03-31 |
| NOVO HOLDINGS A/S | 3650737.00 | $33.99M | 2026-03-31 |
| BVF INC/IL | 2879289.00 | $26.81M | 2026-03-31 |
| STATE STREET CORP | 2707875.00 | $25.21M | 2026-03-31 |
| VANGUARD GROUP INC | 3093527.00 | $23.20M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-17 | |
| Sell | null | 2026-06-01 |
Back to FDMT overview · FDMT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.